Table 1.
Description of the included trials.
| Source | Number of patients | Inclusion criteria | Key exclusion criteria | Clinical follow-up duration, months | |
|---|---|---|---|---|---|
| EES | PES | ||||
| Kedhi et al. [6], 2010 | 897 | 903 | Consecutive patients referred for elective or emergent PCI | Planned major surgery within 30 days | 24 |
|
| |||||
| Garg et al. [5], 2009 | 223 | 77 | Ischemia and vessel size 2.5–4.25 mm and lesion length ≤28 mm | Recent MI, LVEF ≤30%, left main, heavily calcified lesion, or visible thrombus | 48 |
|
| |||||
| Stone et al. [7], 2009 | 669 | 332 | Stable, unstable angina or inducible ischemia with vessel 2.5–3.75 mm diameter and lesion length ≤28 mm | Recent MI, LVEF <30%, LM bifurcation, by-pass graft, calcification, and thrombus | 36 |
|
| |||||
| Stone et al. [8], 2010 | 2458 | 1229 | Angina or ischemia with vessel 2.5–3.75 mm diameter and lesion length ≤28 mm | Recent MI, LVEF <30%, left main bifurcation, total occlusion, heavy calcification, total occlusion, restenosis, and visible thrombus, and vein graft PCI | 24 |
Abbreviations: EES, Everolimus-Eluting Stent; PES, Paclitaxel-Eluting Stent; MI, Myocardial Infarction; LVEF, Left Ventricular Ejection Fraction; PCI, Percutaneous Coronary Intervention.